Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4- furylthiazoles

Journal of Medicinal Chemistry

Volumn 42, Issue 15, 1999, Pages 2920-2926

  Katsura, Yousuke ^a   Nishino, Shigetaka ^a   Ohno, Mitsuko ^a   Sakane, Kazuo ^a   Matsumoto, Yoshimi ^a   Morinaga, Chizu ^a   Ishikawa, Hirohumi ^a   Takasugi, Hisashi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BISMUTH CITRATE; CIMETIDINE; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; GUINEA PIG; HEART ATRIUM; HELICOBACTER PYLORI; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAT; RECEPTOR BLOCKING; STOMACH ACID SECRETION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ATRIAL FUNCTION; COLONY COUNT, MICROBIAL; GASTRIC ACID; GUANIDINES; GUINEA PIGS; HEART ATRIA; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H2; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 0033614932     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9900671     Document Type: Article

References (17)

1. Warren, J. R.; Marshall, B. J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1311-1315.
2. Axon, A. T. R. Eradication of Helicobacter Pylori. Scand. J. Gastroenterol. 1996, 31 (Suppl. 214), 4753.
3. Larry, K. L.; Tanaka, K. Therapy of Helicobacter pylori infections: Current status and future directions. Annu. Rep. Med. Chem. 1995, 151158.
4. Marshall, B. J. Helicobacter pylori. Am. J. Gastroenterol. 1994, 89, s116-s128.
5. Alper, J. Ulcers as an infectious disease. Science 1993, 260, 159-160.
6. Heatley, R. V. The treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 1992, 6, 291-303.
7. Chiba, N.; Rao, B. V.; Rademaker, J. W.; Hunt, R. H. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am. J. Gastroenterol. 1992, 87, 1716-1727.
8. Dooley, C. P. Helicobacter pylori: review of search findings. Aliment. Pharmacol. Ther. 1991, 5 (Suppl. 1), 129-143.
9. Blum, A. L. Helicobacter Pylori and peptic ulcer disease. Scand. J. Gastroenterol. 1996, 31 (Suppl. 214), 24-27.
10. Tytgat, G. N. J.; Lee, A.; Graham, D. Y.; Dixon, M. F.; Rokkas, T. The role of infectious agents in peptic ulcer disease. Gastroenterol. Int. 1993, 6, 76-89.
11. Ateshkadi, A.; Lam, N. P.; Johnson, C. A. Helicobacter pylori and peptic ulcer disease. Clin. Pharmacol. 1993, 12, 34-38.
12. Fletcher, P. J.; Craig, Q. M. The role and treatment of Helicobacter pylori infection in peptic ulcer disease: a review of the relationship between Helicobacter pylori infection and peptic ulcer disease. J. Clin. Pharmacol. Ther. 1993, 18, 311-316.
13. Partipilio, M. L.; Woster, P. S. The role of Helicobacter pylori in peptic ulcer disease. Pharmacotherapy 1993, 13, 330-339.
14. Glupczynski, Y.; Buret, A. Drug therapy for Helicobacter pylori infection: Problems and pitfalls. Am. J. Gastroenterol. 1990, 85, 1545-1551.
15. Katsura, Y.; Inoue, Y.; Tomishi, T.; Itoh, H.; Ishikawa, H.; Takasugi, H. Studies on Antiulcer Drugs. VI. 4-Furyl-2-guanidinothiazoles and Related Compounds as Potent Histamine H2-Receptor Antagonists. Chem. Pharm. Bull. 1992, 40, 2432-2441.
16. Katsura, Y.; Tomishi, T.; Inoue, Y.; Sakane, K.; Matsumoto, Y.; Ishikawa, H.; Takasugi, H. Anti-Helicobacter pylori Agents. 1. 2-Alkylguanidino-4-furylthiazoles and Related Compounds. J. Med. Chem. 1997, 40, 2462-2465.
17. Katsura, Y.; Nishino, S.; Tomishi, T.; Sakane, K.; Matsumoto, Y.; Ishikawa, H.; Takasugi, H. Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles. Bioorg. Med. Chem. Lett. 1998, 8, 1307-1312.